Latham & Watkins has announced that Hui Xu has joined the firm’s Shanghai office as a partner in the Litigation & Trial Department.
Xu’s practice focuses on advising clients on complex, cross border government investigations and litigation matters in Asia. He has deep experience conducting complex internal investigations involving the US Foreign Corrupt Practices Act (FCPA) and Chinese bribery laws, advising clients on matters before the US Department of Justice and China SAIC regulators, performing compliance due diligence for high-profile transactions and presenting bilingual training for senior executives and management teams on compliance with the FCPA and Chinese bribery laws.
Xu has also advised on Committee on Foreign Investment in the US (“CFIUS”) reviews, international trade—including anti-dumping and countervailing duty investigations and WTO disputes—Section 337 investigations, and antitrust matters. He has a wealth of experience and deep knowledge representing Chinese companies and Chinese government agencies in US regulatory compliance matters and litigation across a number of industry sectors including pharmaceutical, life sciences, manufacturing and retail.
Rowland Cheng, Office Managing Partner of Shanghai, said: “Hui is a highly regarded practitioner in his field and we are delighted that he has joined us in China. He has a distinguished track record advising companies, boards and executives on a wide range of ‘big ticket’ litigation. He is calm, thoughtful and tough in hotly-contested matters, and he will add important capabilities to our Corporate and Government Investigations capabilities in the region.”
